Search Tag: butterfly children

2025 27 May

RHEACELL and AOP Health have formed a new strategic partnership to deliver breakthrough therapies for the "butterfly children's" disease and chronic venous wounds. This partnership aims to provide patients with high unmet medical needs access to innovative cell therapies.   RHEACELL, a German biotech company specialised in the development of...Read more